References
- Pereira FA. Herpes simplex: evolving concepts. J Am Acad Dermatol 1996; 35(4): 503–20
- Spruance SL, Freeman DJ, Stewart JC, et al. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis 1991; 163(4): 728–34
- Silverman AK, Laing KF, Swanson NA, et al. Activation of herpes simplex following dermabrasion: report of a patient successfully treated with intravenous acyclovir and brief review of the literature. J Am Acad Dermatol 1985; 13(1): 103–8
- Spruance SL. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol 1993; Suppl 1: 27–32
- Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial. JAMA 1996; 276(l): 44–9
- Diaz-Mitoma F, Sibbald RG, Shafran SD, et al. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. JAMA 1998; 280(10): 887–92
- Reitano M, Tyring S, Lang W, et al. Valacyclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. J Infect Dis 1998; 178(3): 603–10
- Tyring SK, Douglas JM Jr, Corey L, et al. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 1998; 134(2): 185–91
- Spruance SL, Tyring SK, DeGregorio B, et al. A large-scale, placebo-controlled, dose-ranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996; 156(15): 1729–35
- Gilbert S, McBurney E. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: a randomized clinical trial of dosing regimens. Dermatol Surg 2000; 26(l): 50–4
- Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: a multicenter, double blind, placebo-controlled trial. Arch Intern Med 1997; 157(3): 343–9
- Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark. Arch Dermatol 1993; 129(5): 582–7
- Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw- Hill, 1999: 2838–43, 2422–4